Evidence map›Paper›PMID 41768526›Full record

ArticleImaging neuroscience (Cambridge, Mass.)

Unveiling unified patterns in Alzheimer's disease subtypes: An SCCA clustering approach integrating PET imaging and genomics data.

Fan Yang, Matthew Maher, Richa Saxena, Joyita Dutta

Abstract read
In one paragraph

Article in Imaging neuroscience (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Multimodal axes reveal individualized amyloid-medRxiv : the preprint server for health sciences · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fan YangDepartment of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA, United States.
Matthew MaherCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
Richa SaxenaCenter for Genomic Medicine, Massachusetts General Hospital, Boston, MA, United States.
Joyita DuttaDepartment of Biomedical Engineering, University of Massachusetts Amherst, Amherst, MA, United States.ORCID https://orcid.org/0000-0002-6712-4927

Funding

Longitudinal predictive modeling for tau in Alzheimer's diseaseR01AG072669 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI DUTTA, JOYITA · 2021 to 2025
$2.7M
Super-Resolved Multimodal Imaging Biomarkers for Frontotemporal DementiaR21AG087392 · NIA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI DUTTA, JOYITA, SARANATHAN, MANOJKUMAR · 2024 to 2025
$474k
Super-Resolution Tau PET Imaging for Alzheimer's DiseaseR03AG070750 · NIA · UNIVERSITY OF MASSACHUSETTS LOWELL · PI DUTTA, JOYITA · 2021 to 2022
$304k
Early Alzheimers Forecasting from Multimodal Data via Deep Transfer Learning, Evaluated on a Large-Scale Prospective Cohort StudyR03AG083708 · NIA · UNIVERSITY OF MASSACHUSETTS AMHERST · PI DUTTA, JOYITA, FITERAU BROSTEAN, MADALINA · 2023 to 2023
$287k
NIA NIH HHS R01 AG072669NIA NIH HHS R03 AG070750NIA NIH HHS R03 AG083708NIA NIH HHS R21 AG087392
6 · The paper itself

Abstract

Alzheimer's disease (AD) is the most common cause of dementia and a significant public health challenge. AD is characterized by the formation of tau and beta-amyloid (Aβ) protein aggregates in the brain, which can be imaged in vivo using positron emission tomography (PET). Integrating genetic and neuroimaging data using imaging genetics tools offers the potential to better understand disease mechanisms and risk factors in this heterogeneous disorder. Here, we present a framework based on Sparse Canonical Correlation Analysis (SCCA) integrated with clustering to identify AD subtypes from PET and genomic data. The SCCA clustering method was applied to tau PET scans (N = 541), Aβ PET scans (N = 907), and corresponding genomics data from the Alzheimer's Disease Neuroimaging Initiative database. Test-retest studies were used to compare two different SCCA implementations, and longitudinal data were used to assess the stability of the subtyping approach. We identified four tau subtypes and two Aβ subtypes with distinct spatial deposition patterns, consistent with prior imaging studies. Genetic profiles associated with each subtype showed enrichment of specific biological pathways. Our findings suggest that SCCA clustering can help reveal biologically meaningful subtypes of AD. A clearer understanding of AD subtypes could ultimately improve AD diagnosis, prognosis, and treatment strategies.

Indexed as

Alzheimer’s diseaseAβimaging geneticsPETsparse canonical correlation analysistau

Identifiers

PMID41768526
PMCPMC12938741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.